SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Wolf, R.
Right arrow Articles by Emrich, H. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wolf, R.
Right arrow Articles by Emrich, H. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Valproate effects on pre-optic GABA release and pituitary LH secretion in the rat

Rainer Wolf

Max-Planck-Institute for Psychiatry, Clinical Institute, Kraepelinstr. 2, D-8000 Munich 40, Germany

Ursula Tscherne

Max-Planck-Institute for Psychiatry, Clinical Institute, Kraepelinstr. 2, D-8000 Munich 40, Germany

Hinderk M. Emrich

Max-Planck-Institute for Psychiatry, Clinical Institute, Kraepelinstr. 2, D-8000 Munich 40, Germany

The in vivo effects of the anticonvulsant drug sodium valproate (VPA) on pre-optic gamma-aminobutyric acid (GABA) release and pituitary luteinizing hormone (LH) secretion were studied by perfusing the pre-optic area of unanaesthetized, freely moving ovarectomized rats through push-pull cannulae at a flow-rate of 20 >µl/min with a fraction period of 15 min. Local treatment with 40, 100, 400 and 1600 µg VPA/ml differently affected pre-optic GABA release and pituitary LH secretion concerning mean level, mean pulse amplitude and mean pulse frequency. GABA levels in perfusate were suppressed by local treatment with 40 and 100 µg VPA/ml CSF, respectively, whereas no significant change could be observed at the highest concentration used (1600 µg VPA/ml CSF). Pituitary LH secretion was reduced by pre-optic perfusion with 100 µg VPA/ml CSF with regard to mean plasma level and pulse amplitude but no significant change in pulse frequency could be observed. By raising VPA concentration the effects became more pronounced, and at 1600 µ g VPA/ml CSF there was a marked reduction of LH secretion regarding mean plasma level, amplitude and frequency. In conclusion, the present data put forward our view that the mechanism of action of VPA generates an enhancement of GABAergic transmission different from that involving elevated extracellular GABA.

Key Words: valproate • GABA • LH secretion • pre-optic

Journal of Psychopharmacology, Vol. 6, No. 2, 265-272 (1992)
DOI: 10.1177/026988119200600220


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
R. Wolf, F. Strehle, and H. M. Emrich
In vivo effects of carbamazepine and haloperidol on GABA neurotransmission and LH secretion
J Psychopharmacol, January 1, 1995; 9(1): 25 - 31.
[Abstract] [PDF]



Advertisement